相关临床试验
1
0 进行中
药物批准
0
批准总数
监管机构
0
监管机构数
成立时间
N/A
暂无试验阶段数据
已完成
1
100.0%
暂无批准数据
- A 69-year-old woman's persistent abdominal bloating was ultimately diagnosed as Stage 4 ovarian cancer after a nurse practitioner ordered a CT scan instead of the expected colonoscopy. - Oncologist Dr. Premal Thaker of Washington University School of Medicine describes ovarian cancer as "very insidious," with subtle symptoms that mimic menopause or milder conditions. - Patients with Stage 4 ovarian cancer have roughly a 30% five-year survival chance, and about 70% of patients will see their disease return, according to cited organizations. - The patient's treatment combined neoadjuvant chemotherapy, February 2025 surgery including hysterectomy, resumed chemotherapy, immunotherapy infusions, and an ongoing daily chemotherapy pill.
- At the TIME100 Health Leadership Forum in New York, oncology experts named vaccines, immunotherapy, early detection and prevention as the most promising fronts in cancer research. - American Cancer Society CEO Shane Jacobson credited philanthropic and federal funding for rapid innovation, citing Moderna and Merck's encouraging mRNA cancer vaccine results. - Memorial Sloan Kettering oncologist Andrea Cercek cited a 2024 rectal cancer study in which no patient had detectable tumors after six months of immunotherapy. - Cercek said she is 'very close' to extending this immunotherapy approach to other cancers, and predicted early detection and prevention will ultimately cure cancer.
- The STAMINA lifestyle intervention reduced deterioration in quality of life by as much as one-third in men receiving androgen deprivation therapy for prostate cancer, researchers reported in The Lancet Oncology. - In the 700-patient UK trial across 15 NHS hospitals, more than 80% of participants attended scheduled supervised exercise sessions over the 12-month study period. - Economic modelling showed the program costs well below standard NHS thresholds for cancer interventions and is expected to remain cost-effective for up to a decade. - Nuffield Health has launched a Cancer Activity Programme based on STAMINA, committing to fund 50,000 places by 2030 with planned expansion to breast and bowel cancer.
- The American Cancer Society plans to build Hope Lodge Chicago at 5700 S. Stony Island Ave., providing free lodging for cancer patients and caregivers traveling for treatment. - UChicago Medicine serves as the primary partner, with the University of Chicago providing the property via long-term lease and contributing construction funds. - The facility will sit about one mile from the new AbbVie Foundation Cancer Pavilion, a 575,000-square-foot cancer center opening in April 2027. - Hope Lodge communities nationwide already serve more than 36,000 patients and caregivers annually, saving over $85 million in lodging costs each year.
- A nationally representative study of 17,024 U.S. men found higher ultra-processed food intake was associated with a 24% to 31% greater risk of prostate cancer after adjustment. - Men in the two highest consumption groups showed a 30% greater risk, while the highest-intake group alone had a possible 34% increase that did not reach statistical significance. - Ultra-processed foods supply nearly 60% of calories for U.S. adults and about 70% for children, underscoring the public health relevance of the findings. - Researchers call for large-scale observational studies and randomized trials to confirm the association and inform dietary guidance.
- Natalie Harp, a White House aide, publicly credits the 2018 Right to Try law with saving her life after she failed chemotherapies for a rare Stage 2 bone cancer and was denied clinical trial participation. - Medical experts note a key contradiction: Harp says she received an FDA-approved immunotherapy drug for an unapproved use, but Right to Try applies only to drugs not approved for any use. - Such off-label use of an approved immunotherapy would instead fall under the FDA's expanded access pathway, which has existed since 1987 and predates the Right to Try Act. - Bone cancers are rare and frequently chemotherapy-resistant, and immunotherapy represents a promising emerging treatment avenue, lending plausibility to parts of Harp's account.
- Speed of Light – The ASTRO Foundation announced $2.4 million in new research grants supporting 14 scientists working to advance patient care in radiation medicine. - The 2026 awards are the first annual grants since ASTRO relaunched its foundation as Speed of Light, with a renewed focus on accelerating research and strengthening the radiation oncology workforce. - Grants are made possible through partnerships with leading cancer research organizations, including the American Cancer Society, AAPM, the Breast Cancer Research Foundation, LUNGevity Foundation, and the Prostate Cancer Foundation. - Since 2013, ASTRO and its Foundation have awarded $15.8 million to more than 150 research teams, who have subsequently attracted over $90 million in follow-on funding.
- A large ACS and NCI study using SEER-Medicare data finds cancer-attributable medical costs average $121,746 per year in the end-of-life phase, compared to $45,063 in the initial phase and $7,141 in continuing care. - Oral prescription drug costs rose sharply across all phases of care, with end-of-life drug costs climbing from $4,823 in 2013 to $11,620 in 2019, while hospitalization costs remained stable after inflation adjustment. - Distant-stage cancers incurred the highest costs; for example, first-year colorectal cancer costs were $49,000 for early-stage versus $116,000 for advanced-stage disease. - Researchers and ACS CAN leadership emphasize that the findings underscore the critical importance of cancer prevention, early detection, and affordable comprehensive health insurance to mitigate financial hardship.
- Elective whole-body MRI scans are gaining traction through social media promotion, with companies like Prenuvo marketing them for early cancer and disease detection. - Major medical organizations including the American Cancer Society and American College of Radiology do not recommend these scans for asymptomatic individuals due to insufficient evidence of benefit. - Approximately one in five patients receives a finding requiring follow-up, yet many abnormalities ultimately prove harmless, leading to unnecessary anxiety, testing, and procedures. - Research cited in JAMA found that ovarian cancer screening in asymptomatic women did not improve mortality outcomes while leading to over 1,000 unnecessary surgeries.
- Less than 20% of young adults aged 18–39 with advanced cancer received guideline-recommended concurrent palliative care alongside systemic treatment between 2021 and 2023, despite utilization doubling from 9.3% in 2010 to 18.3% in 2023. - Lung cancer patients had the highest concurrent palliative care utilization at 39.1%, while Hodgkin lymphoma patients had the lowest at just 1.9%, revealing stark disparities by cancer type. - American Cancer Society researchers analyzed 67,706 patients from the National Cancer Database and called for policy action including passage of the Palliative Care and Hospice Education and Training Act. - Experts emphasize that palliative care should be integrated early and consistently into oncology care for all advanced cancer patients, not limited to end-of-life settings.
